What Analysts Are Saying About Cushman & Wakefield Stock
Benzinga Insights 1 year ago
Analyst Ratings
Cushman & Wakefield (NYSE:CWK) has been analyzed by 6 analysts in the last three months, revealing a diverse range of perspectives from bullish to bearish.
Summarizing their recent assessments, the table below illustrates the evolving sentiments in the past 30 days and compares them to the preceding months.
| Bullish | Somewhat Bullish | Indifferent | Somewhat Bearish | Bearish | |
|---|---|---|---|---|---|
| Total Ratings | 2 | 3 | 1 | 0 | 0 |
| Last 30D | 1 | 0 | 0 | 0 | 0 |
| 1M Ago | 1 | 2 | 0 | 0 | 0 |
| 2M Ago | 0 | 0 | 1 | 0 | 0 |
| 3M Ago | 0 | 1 | 0 | 0 | 0 |
Insights from analysts' 12-month price targets are revealed, presenting an average target of $15.83, a high estimate of $20.00, and a low estimate of $12.00. This current average has increased by 14.05% from the previous average price target of $13.88.
Breaking Down Analyst Ratings: A Detailed Examination
The standing of Cushman & Wakefield among financial experts becomes clear with a thorough analysis of recent analyst actions. The summary below outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.
| Analyst | Analyst Firm | Action Taken | Rating | Current Price Target | Prior Price Target |
|---|---|---|---|---|---|
| Julien Blouin | Goldman Sachs | Raises | Buy | $20.00 | $17.50 |
| Julien Blouin | Goldman Sachs | Announces | Buy | $17.50 | - |
| Mitch Germain | JMP Securities | Raises | Market Outperform | $16.00 | $15.00 |
| Mitch Germain | JMP Securities | Announces | Market Outperform | $15.00 | - |
| Alex Kramm | UBS | Raises | Neutral | $12.00 | $9.00 |
| Richard Hill | Morgan Stanley | Raises | Overweight | $14.50 | $14.00 |
Key Insights:
- Action Taken: Analysts respond to changes in market conditions and company performance, frequently updating their recommendations. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their reaction to recent developments related to Cushman & Wakefield. This information offers a snapshot of how analysts perceive the current state of the company.
- Rating: Delving into assessments, analysts assign qualitative values, from 'Outperform' to 'Underperform'. These ratings communicate expectations for the relative performance of Cushman & Wakefield compared to the broader market.
- Price Targets: Analysts gauge the dynamics of price targets, providing estimates for the future value of Cushman & Wakefield's stock. This comparison reveals trends in analysts' expectations over time.
To gain a panoramic view of Cushman & Wakefield's market performance, explore these analyst evaluations alongside essential financial indicators. Stay informed and make judicious decisions using our Ratings Table.
Stay up to date on Cushman & Wakefield analyst ratings.
Unveiling the Story Behind Cushman & Wakefield
Cushman & Wakefield is one of the largest commercial real estate services firms in the world, with global headquarters in Chicago. The firm provides various real estate-related services to owners, occupiers, and investors. These include brokerage services for leasing and capital markets sales as well as advisory services such as valuation, project management, and facilities management.
Key Indicators: Cushman & Wakefield's Financial Health
Market Capitalization Perspectives: The company's market capitalization falls below industry averages, signaling a relatively smaller size compared to peers. This positioning may be influenced by factors such as perceived growth potential or operational scale.
Revenue Growth: Cushman & Wakefield displayed positive results in 3M. As of 30 June, 2025, the company achieved a solid revenue growth rate of approximately 8.56%. This indicates a notable increase in the company's top-line earnings. As compared to competitors, the company encountered difficulties, with a growth rate lower than the average among peers in the Real Estate sector.
Net Margin: Cushman & Wakefield's net margin is impressive, surpassing industry averages. With a net margin of 2.31%, the company demonstrates strong profitability and effective cost management.
Return on Equity (ROE): Cushman & Wakefield's financial strength is reflected in its exceptional ROE, which exceeds industry averages. With a remarkable ROE of 3.11%, the company showcases efficient use of equity capital and strong financial health.
Return on Assets (ROA): Cushman & Wakefield's financial strength is reflected in its exceptional ROA, which exceeds industry averages. With a remarkable ROA of 0.77%, the company showcases efficient use of assets and strong financial health.
Debt Management: Cushman & Wakefield's debt-to-equity ratio surpasses industry norms, standing at 1.7. This suggests the company carries a substantial amount of debt, posing potential financial challenges.
Understanding the Relevance of Analyst Ratings
Analysts work in banking and financial systems and typically specialize in reporting for stocks or defined sectors. Analysts may attend company conference calls and meetings, research company financial statements, and communicate with insiders to publish "analyst ratings" for stocks. Analysts typically rate each stock once per quarter.
Analysts may supplement their ratings with predictions for metrics like growth estimates, earnings, and revenue, offering investors a more comprehensive outlook. However, investors should be mindful that analysts, like any human, can have subjective perspectives influencing their forecasts.
Breaking: Wall Street's Next Big Mover
Benzinga's #1 analyst just identified a stock poised for explosive growth. This under-the-radar company could surge 200%+ as major market shifts unfold. Click here for urgent details.
This article was generated by Benzinga's automated content engine and reviewed by an editor.